Cite
HARVARD Citation
Maher‐Edwards, G. et al. (2015). A 24‐week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease. Alzheimer's & dementia. 1 (2), pp. 131-140. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maher‐Edwards, G. et al. (2015). A 24‐week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease. Alzheimer's & dementia. 1 (2), pp. 131-140. [Online].